About the Company
PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®." This technology is being used as a platform upon which therapies for several types of cancer and diabetes are being developed. PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or "cancer-killing" form.
Employees
4
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PMCB News
PMCB Stock Earnings: PharmaCyte Biotech Reported Results for Q3 2024
PharmaCyte Biotech (NASDAQ:PMCB) just reported results for the third quarter of 2024. PharmaCyte Biotech reported earnings ...
PharmaCyte Biotech (PMCB) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Wayne Remell Walker's Net Worth
PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $2.3 ...
PharmaCyte Biotech Inc PMCB
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
PharmaCyte Biotech, Inc. Common Stock (PMCB)
Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ...
PharmaCyte Biotech Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
PharmaCyte Biotech, Inc. Common Stock (PMCB)
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...
PharmaCyte Biotech Inc (PMCB)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
PharmaCyte Biotech, Inc. (PMCB)
LAS VEGAS, November 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) ("Femasys"), a ...
Loading the latest forecasts...